|
Name |
5,8-dihydroxy-10-methoxy-2-methyl-4H-benzo[h]chromen-4-one
|
| Molecular Formula | C15H12O5 | |
| IUPAC Name* |
4,5-dihydroxy-10-methoxy-2-methylbenzo[h]chromen-8-one
|
|
| SMILES |
CC1=CC(=C2C(=CC3=CC(=O)C=C(C3=C2O1)OC)O)O
|
|
| InChI |
InChI=1S/C15H12O5/c1-7-3-10(17)14-11(18)5-8-4-9(16)6-12(19-2)13(8)15(14)20-7/h3-6,17-18H,1-2H3
|
|
| InChIKey |
NSAPXJZXVFHIHJ-UHFFFAOYSA-N
|
|
| Synonyms |
TMC-256C1; CHEMBL454794; SCHEMBL15060672; TMC 256C1; BDBM50242177; 5,8-dihydroxy-10-methoxy-2-methyl-benzo[h]chromen-4-one; 5,8-dihydroxy-10-methoxy-2-methyl-4H-benzo[h]chromen-4-one; 5,8-dihydroxy-10-methoxy-2-propyl-4H-benzo[h]chromen-4-one
|
|
| CAS | NA | |
| PubChem CID | 135418331 | |
| ChEMBL ID | CHEMBL454794 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 272.25 | ALogp: | 0.7 |
| HBD: | 2 | HBA: | 5 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 76.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 20 | QED Weighted: | 0.663 |
| Caco-2 Permeability: | -4.869 | MDCK Permeability: | 0.00000843 |
| Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.698 |
| Human Intestinal Absorption (HIA): | 0.029 | 20% Bioavailability (F20%): | 0.013 |
| 30% Bioavailability (F30%): | 0.964 |
| Blood-Brain-Barrier Penetration (BBB): | 0.016 | Plasma Protein Binding (PPB): | 86.75% |
| Volume Distribution (VD): | 0.79 | Fu: | 12.45% |
| CYP1A2-inhibitor: | 0.976 | CYP1A2-substrate: | 0.963 |
| CYP2C19-inhibitor: | 0.163 | CYP2C19-substrate: | 0.096 |
| CYP2C9-inhibitor: | 0.536 | CYP2C9-substrate: | 0.864 |
| CYP2D6-inhibitor: | 0.628 | CYP2D6-substrate: | 0.574 |
| CYP3A4-inhibitor: | 0.252 | CYP3A4-substrate: | 0.172 |
| Clearance (CL): | 9.957 | Half-life (T1/2): | 0.743 |
| hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.08 |
| Drug-inuced Liver Injury (DILI): | 0.96 | AMES Toxicity: | 0.653 |
| Rat Oral Acute Toxicity: | 0.11 | Maximum Recommended Daily Dose: | 0.912 |
| Skin Sensitization: | 0.873 | Carcinogencity: | 0.09 |
| Eye Corrosion: | 0.052 | Eye Irritation: | 0.936 |
| Respiratory Toxicity: | 0.528 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001770 | ![]() |
0.662 | D06GCK | ![]() |
0.363 | ||
| ENC003794 | ![]() |
0.518 | D07MGA | ![]() |
0.349 | ||
| ENC002523 | ![]() |
0.507 | D04AIT | ![]() |
0.345 | ||
| ENC000962 | ![]() |
0.507 | D0FA2O | ![]() |
0.342 | ||
| ENC006014 | ![]() |
0.500 | D0G4KG | ![]() |
0.333 | ||
| ENC002113 | ![]() |
0.477 | D0K8KX | ![]() |
0.322 | ||
| ENC001631 | ![]() |
0.474 | D0AZ8C | ![]() |
0.264 | ||
| ENC005649 | ![]() |
0.474 | D08SKH | ![]() |
0.263 | ||
| ENC005191 | ![]() |
0.467 | D0E9CD | ![]() |
0.250 | ||
| ENC001653 | ![]() |
0.467 | D0D4HN | ![]() |
0.250 | ||